Massimiliano Veroux, MD, PhD graduated in School of Medicine, University of Catania in 1996. He subsequently completed his 6-years General Surgery training at the University of Catania and University of Padua. Prof. Veroux has joined the faculty of the University of Catania in 2007 as an Associate Professor of General Surgery and is currently the Chief of Kidney Transplant Program at the University of Catania.   Prof. Veroux has an academic interest in traslational and clinical research in organ transplantation. He was involved in many international peer-reviewed and industry-funded clinical trials on the development of new immunosuppressive regimens in kidney transplant recipients. He was the recipient of the Italian Ministry of Health Grant in 2015, entitled “The gastric submucosal space and lymph nodes as alternative sites for islet allo-transplantation using clinically applicable immunosuppression”, which demonstrated for the first time that lymph nodes could not be used for islet transplantation. The research project was performed in collaboration with the University of Pittsburgh and the Allegheny Research Institute of Pittsburgh, Pennsylvania, USA. In addition, he is involved in clinical outcome research in patients undergoing transplantation, including de novo post-transplant cancer and the management of post-transplant infections.   Starting from 2017, he serves as a Faculty member of the Spin-Off Petalo of the University of Catania, which holds an international patent of a devices for the treatment of large veins diseases. For this research, Prof Veroux was awarded another national grant from the Italian Ministry of Health in 2018, entitled “Novel compliant scaffold with specific design for the treatment of non-thrombotic stenosis of internal jugular veins in patients with chronic headache poor responder to best medical therapy”.   For long time, he has been interested in Fabry disease and Fabry disease-associated nephropathy. He was involved in many multicentre studies on Fabry disease, exploring the clinical symptoms which are suggestive of progression of the disease. He is currently the Director of “Multidisciplinary Research Center for the diagnosis and the treatment of Fabry disease and organ transplantation” of the University of Catania, which has been developed for the first time in Italy, as a multidisplinary group focused on the diagnosis and management of Fabry disease. Under his directorship, the Center is focused on research projects aiming to find early clinical and biological markers of Fabry disease.   Prof. Veroux won several awards and recognitions with his scientific studies from the Italian Society of Surgery, the Consorzio Interuniversitario per i Trapianti d’organo, the Clinical Infectious Disease journal, the European Society of Surgery, and the European Society of Organ Transplantation. He is an active member of several scientific societies, including American Society of Transplantation, European Society of Surgery, The Transplantation Society. He has published over 220 peer-reviewed publications and 33 book chapters and has given 97 invited lectures nationally and internationally. He served as a reviewer in more than 60 peer-reviewed journals. He is an editorial board member of many international peer-reviewed journals as well as an Associate Editor of BMC Cancer and BMC Surgery.